Clinical Trial Results

Showing: All studies [change]
Condition: Lupus Location: Connecticut 12 trials found
New Search
Filter
Trial Phase
Study Type
NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care
N/AOBSERVATIONAL Altenburg +4 more
RECRUITING
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
PHASE1INTERVENTIONAL Avondale, Arizona +4 more
RECRUITING
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus
NAINTERVENTIONAL Freiburg im Breisgau, Baden-Wurttemberg +4 more
RECRUITING
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
N/AOBSERVATIONAL La Jolla, California +4 more
RECRUITING
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Avondale, Arizona +4 more
RECRUITING
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
PHASE1INTERVENTIONAL La Jolla, California +4 more
RECRUITING
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
PHASE1INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type